Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Julie Rubinstein currently holds 148,770 shares of Adaptive Biotechnologies Corp (ADPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julie Rubinstein has been a net seller of ADPT stock. They have purchased $0 and sold $71.3M worth of shares.
Julie Rubinstein's most recent insider trade was on Apr 16, 2026, when they sold 14,722 shares at $0.00 per share.
Julie Rubinstein serves as Executive at Adaptive Biotechnologies Corp (ADPT). They have executed 252 insider transactions totaling $71.3M over their tenure at the company.
Julie Rubinstein holds the position of Executive at Adaptive Biotechnologies Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Julie Rubinstein has shown a selling trading pattern, with $0 in total purchases and $71.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Julie Rubinstein was on Feb 26, 2021, when they sold $843.5K worth of ADPT shares. This transaction involved 15,000 shares at $56.23 per share.
Julie Rubinstein currently owns 148,770 shares of Adaptive Biotechnologies Corp (ADPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Julie Rubinstein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Julie Rubinstein has 252 Form 4 filings on record as an insider at Adaptive Biotechnologies Corp.
Set alerts for Julie Rubinstein and 40,000+ other insiders.